drugset / Trial / NCT00595543

Treatment of Acute Pseudophakic Cystoid Macular Edema: Bromfenac 0.09% Versus Diclofenac Sodium 0.1% Versus Ketorolac Tromethamine 0.5%

NCT00595543

Phase 4 Completed 166 enrolled Bp Consulting, Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare bromfenac 0.09%, diclofenac sodium 0.1%, and ketorolac tromethamine 0.5% ophthalmic solutions for the treatment of acute pseudophakic CME after cataract surgery.

Timeline

Start
2008-01
Primary completion
2009-03
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bromfenac Other / unclassified 0.09 % Other
Comparator Diclofenac Other / unclassified 0.1 % Other
Comparator Ketorolac Other / unclassified 0.5 % Other

Indications